Pathologic analysis of the national surgical adjuvant breast project (NSABP) B-17 trial. Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ
Open Access
- 15 March 1995
- Vol. 75 (6), 1219-1222
- https://doi.org/10.1002/1097-0142(19950315)75:6<1219::aid-cncr2820750602>3.0.co;2-x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Ductal carcinoma in situ of the breast. Heterogeneity of individual lesionsCancer, 1994
- One Century of Mammary Carcinoma In Situ:What Have We Learned?American Journal of Clinical Pathology, 1993
- Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast CancerNew England Journal of Medicine, 1993
- Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatmentCancer, 1993
- Noninvasive ductal carcinoma of the breast: The relevance of histologic categorizationHuman Pathology, 1993
- Ductal Carcinoma In Situ of the Female BreastThe American Journal of Surgical Pathology, 1992
- Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance aloneCancer, 1992
- Duct Carcinoma in Situ: Pathology and TreatmentSurgical Clinics of North America, 1990
- Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrenceCancer, 1989
- Heterogeneity of intraductai carcinoma of the breastCancer, 1989